Pheochromocytomas and Paragangliomas
Jul 07, 2025
Current Pheochromocytomas and Paragangliomas Treatment Paradigms: Challenges and Opportunities
The metastatic pheochromocytomas and paragangliomas treatment landscape has seen notable progress alongside ongoing challenges. Although curative therapies are still lacking, patients benefit from a multidisciplinary care strategy involving debulking surgery, chemotherapy, tyrosine kinase inhibitors, immunotherapy,...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
